SCHEMBL5654038

SCHEMBL5654038

CCc1ccc(-c2ccc(C(=O)NCC(=O)NC(C)c3ccccc3)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAOK1 Q7L7X3 4/20 1.00
TAOK3 Q9H2K8 3/20 1.00
GPR139 Q6DWJ6 13/20 0.74
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
ATM Q13315 1/20 0.59
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
HPGD P15428 1/20 0.59
ROCK2 O75116 1/20 0.56
RPS6KA5 O75582 1/20 0.56
MAP4K4 O95819 1/20 0.56
CDK1 P06493 1/20 0.56
CSF1R P07333 1/20 0.56
PRKACA P17612 1/20 0.56
FLT1 P17948 1/20 0.56
RPS6KB1 P23443 1/20 0.56
CDK2 P24941 1/20 0.56
MAPK1 P28482 1/20 0.56
AKT1 P31749 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5654952 0.87 TAOK1 (1.00) TAOK1TAOK3GPR139MAPT
SCHEMBL10722894 0.83 ALDH1A1 (0.74) TAOK1TAOK3GPR139MEN1KMT2A
SCHEMBL14422176 0.80 TAOK1 (0.73) TAOK1TAOK3ALDH1A1MAPTROCK2
SCHEMBL5654217 0.78 TAOK1 (0.63) TAOK1TAOK3MEN1KMT2AMAPT
SCHEMBL403002 0.76 TAOK1 (0.61) TAOK1TAOK3GPR139MAPT
SCHEMBL23975221 0.74 GPR139 (1.00) GPR139MEN1KMT2AATM
SCHEMBL30518967 0.74 GPR139 (1.00) GPR139MEN1KMT2AATM
SCHEMBL18560352 0.74 TAOK1 (0.58) TAOK1TAOK3GPR139MAPT
SCHEMBL402544 0.74 TAOK1 (0.58) TAOK1TAOK3MEN1KMT2AMAPT
SCHEMBL14083017 0.74 NPC1 (0.61) TAOK1TAOK3ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070208166-A1 Tao Kinase Modulators And Method Of Use EXELIXIS, INC. (US) 2007-09-06 US claimed
US-20250354151-A1 INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) 2025-11-20 US disclosed
EP-4534091-A1 INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION (JP) 2025-04-09 EP disclosed
US-20070208166-A1 Tao Kinase Modulators And Method Of Use EXELIXIS, INC. (US) 2007-09-06 US disclosed
US-20070208166-A1 Tao Kinase Modulators And Method Of Use EXELIXIS, INC. (US) 2007-09-06 US disclosed
US-20070208166-A1 Tao Kinase Modulators And Method Of Use EXELIXIS, INC. (US) 2007-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250354151-A1 INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE TNNI3, TNNC1, TNNT2 TAOK1 7/4885TAOK3 16/4885GPR139 2247/4885
US-20070208166-A1 Tao Kinase Modulators And Method Of Use TAOK1, TAOK3, MAP3K6 TAOK1 1/4885TAOK3 2/4885GPR139 4299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.